Free Trial

Vita Coco (COCO) Financials

Vita Coco logo
$68.64 +0.85 (+1.25%)
Closing price 04:00 PM Eastern
Extended Trading
$67.62 -1.02 (-1.48%)
As of 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Vita Coco

Annual Income Statements for Vita Coco

This table shows Vita Coco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
9.42 33 19 7.81 47 56 73
Consolidated Net Income / (Loss)
9.42 33 19 7.81 47 56 71
Net Income / (Loss) Continuing Operations
9.42 33 19 7.81 47 56 71
Total Pre-Tax Income
11 44 24 11 58 71 93
Total Operating Income
13 47 25 3.06 56 74 83
Total Gross Profit
93 105 113 103 181 199 223
Total Revenue
284 311 380 428 494 516 610
Operating Revenue
284 311 380 428 494 516 610
Total Cost of Revenue
191 206 266 324 313 317 387
Operating Cost of Revenue
191 206 266 324 313 317 387
Total Operating Expenses
80 58 89 100 124 125 140
Selling, General & Admin Expense
79 74 89 100 124 125 140
Total Other Income / (Expense), net
-1.97 -3.26 -0.36 7.79 1.43 -3.03 10
Interest & Investment Income
0.23 0.40 0.13 0.05 2.55 6.72 6.55
Other Income / (Expense), net
-1.03 -2.87 0.01 7.99 -1.12 -9.75 3.89
Income Tax Expense
1.98 11 5.24 3.03 11 15 22
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - - - -0.35 0.21 -1.35
Basic Earnings per Share
$0.17 $0.56 $0.35 $0.14 $0.83 $0.99 $1.25
Weighted Average Basic Shares Outstanding
56.97M 58.50M 53.69M 55.73M 56.43M 56.73M 56.91M
Diluted Earnings per Share
$0.16 $0.56 $0.35 $0.14 $0.79 $0.94 $1.19
Weighted Average Diluted Shares Outstanding
57.15M 58.61M 54.19M 56.12M 58.75M 59.29M 59.97M
Weighted Average Basic & Diluted Shares Outstanding
- - 55.56M 56.05M 56.93M 56.99M 57.08M

Quarterly Income Statements for Vita Coco

This table shows Vita Coco's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
15 6.77 14 19 19 3.37 19 23 24 6.87 30
Consolidated Net Income / (Loss)
15 6.77 14 19 19 3.37 19 23 24 5.53 30
Net Income / (Loss) Continuing Operations
15 6.77 14 19 19 3.37 19 23 24 5.53 30
Total Pre-Tax Income
19 7.96 18 26 26 1.65 24 28 31 9.76 37
Total Operating Income
24 5.42 19 30 21 4.29 19 25 28 10 34
Total Gross Profit
56 40 47 59 52 41 48 61 69 45 72
Total Revenue
138 106 112 144 133 127 131 169 182 128 180
Operating Revenue
138 106 112 144 133 127 131 169 182 128 180
Total Cost of Revenue
82 66 65 85 81 86 83 107 114 83 108
Operating Cost of Revenue
82 66 65 85 81 86 83 107 114 83 108
Total Operating Expenses
33 34 28 29 31 37 29 36 41 34 38
Selling, General & Admin Expense
33 34 28 29 31 37 29 36 41 34 38
Total Other Income / (Expense), net
-4.35 2.54 -0.94 -4.47 5.02 -2.63 5.07 3.05 2.76 -0.44 3.86
Interest & Investment Income
0.82 1.48 1.52 1.63 1.88 1.69 1.52 1.50 1.78 1.75 1.56
Other Income / (Expense), net
-5.17 1.07 -2.47 -6.10 3.14 -4.32 3.55 1.55 0.98 -2.19 2.30
Income Tax Expense
4.01 1.19 3.78 6.42 6.36 -1.72 5.48 5.26 6.68 4.23 6.97
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - - - - - -0.50 - - - 0.46
Basic Earnings per Share
$0.27 $0.12 $0.25 $0.34 $0.34 $0.06 $0.33 $0.40 $0.42 $0.10 $0.53
Weighted Average Basic Shares Outstanding
56.49M 56.43M 56.59M 56.71M 56.77M 56.73M 56.99M 56.80M 56.85M 56.91M 57.11M
Diluted Earnings per Share
$0.26 $0.10 $0.24 $0.32 $0.32 $0.06 $0.31 $0.38 $0.40 $0.10 $0.50
Weighted Average Diluted Shares Outstanding
59.27M 58.75M 58.75M 59.24M 59.31M 59.29M 59.98M 59.64M 59.88M 59.97M 60.47M
Weighted Average Basic & Diluted Shares Outstanding
56.76M 56.93M 56.68M 56.78M 56.73M 56.99M 56.73M 56.82M 56.95M 57.08M 57.11M

Annual Cash Flow Statements for Vita Coco

This table details how cash moves in and out of Vita Coco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
11 35 -43 -9.06 113 33 32
Net Cash From Operating Activities
22 33 -16 -11 107 43 47
Net Cash From Continuing Operating Activities
22 33 -16 -11 107 43 47
Net Income / (Loss) Continuing Operations
9.42 33 19 7.81 47 56 71
Consolidated Net Income / (Loss)
9.42 33 19 7.81 47 56 71
Depreciation Expense
2.08 2.13 2.07 1.90 0.66 0.75 1.07
Amortization Expense
- 0.00 0.00 1.06 0.00 1.02 0.02
Non-Cash Adjustments To Reconcile Net Income
3.31 2.37 3.70 17 11 11 14
Changes in Operating Assets and Liabilities, net
6.95 -3.95 -41 -39 49 -25 -40
Net Cash From Investing Activities
-1.01 -0.38 -0.56 -0.98 -0.59 -0.97 -8.25
Net Cash From Continuing Investing Activities
-1.01 -0.38 -0.56 -0.98 -0.59 -0.97 -8.25
Purchase of Property, Plant & Equipment
-1.01 -0.39 -0.56 -0.98 -0.60 -0.97 -8.15
Acquisitions
- - - - 0.00 0.00 -0.10
Sale of Property, Plant & Equipment
0.00 0.02 0.00 0.00 0.01 0.00 0.00
Net Cash From Financing Activities
-10 2.05 -27 3.03 6.29 -8.30 -7.53
Net Cash From Continuing Financing Activities
-10 2.05 -27 3.03 6.29 -8.30 -7.53
Repayment of Debt
-10 -17 -55 -22 -0.02 -0.01 -0.01
Repurchase of Common Equity
-0.04 -6.94 -50 0.00 -0.77 -12 -11
Other Financing Activities, net
0.01 0.89 18 3.06 7.09 3.75 3.75
Effect of Exchange Rate Changes
0.87 0.44 0.04 -0.18 0.39 -0.56 0.83
Cash Interest Paid
1.13 0.81 0.35 0.22 0.08 0.00 0.00

Quarterly Cash Flow Statements for Vita Coco

This table details how cash moves in and out of Vita Coco's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
47 38 -9.56 27 7.53 7.97 -11 13 37 -6.83 5.04
Net Cash From Operating Activities
44 37 -0.27 27 9.33 6.92 -9.80 22 39 -3.90 16
Net Cash From Continuing Operating Activities
44 37 -0.27 27 9.33 6.92 -9.80 22 39 -3.90 16
Net Income / (Loss) Continuing Operations
15 6.77 14 19 19 3.37 19 23 24 5.53 30
Consolidated Net Income / (Loss)
15 6.77 14 19 19 3.37 19 23 24 5.53 30
Depreciation Expense
0.16 0.16 0.16 0.18 0.20 0.21 0.20 0.21 0.23 0.44 0.48
Amortization Expense
0.41 0.32 0.25 0.25 0.26 0.26 0.00 -0.50 0.01 0.01 0.01
Non-Cash Adjustments To Reconcile Net Income
2.96 2.01 2.64 1.68 1.68 4.54 3.12 3.88 4.16 3.75 4.88
Changes in Operating Assets and Liabilities, net
25 28 -18 5.71 -12 -1.45 -32 -4.69 11 -14 -20
Net Cash From Investing Activities
-0.05 -0.07 -0.12 -0.29 -0.44 -0.13 -0.56 -0.95 -3.41 -3.33 -0.46
Net Cash From Continuing Investing Activities
-0.05 -0.07 -0.12 -0.29 -0.44 -0.13 -0.56 -0.95 -3.41 -3.33 -0.46
Purchase of Property, Plant & Equipment
-0.05 -0.07 -0.12 -0.29 -0.44 -0.13 -0.56 -0.95 -3.41 -3.23 -0.46
Net Cash From Financing Activities
3.19 0.39 -9.09 0.52 -1.80 2.07 -1.10 -7.98 1.15 0.40 -9.90
Net Cash From Continuing Financing Activities
3.19 0.39 -9.09 0.52 -1.80 2.07 -1.10 -7.98 1.15 0.40 -9.90
Repayment of Debt
-0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Repurchase of Common Equity
- -0.77 -9.24 - -2.80 - -1.50 -8.55 -0.15 -1.07 -12
Other Financing Activities, net
3.20 1.17 0.15 0.53 1.00 2.07 0.40 0.57 1.30 1.46 1.61
Effect of Exchange Rate Changes
-0.16 0.18 -0.08 -0.03 0.44 -0.90 0.40 0.56 -0.13 0.00 -0.20

Annual Balance Sheets for Vita Coco

This table presents Vita Coco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
184 197 198 286 362 461
Total Current Assets
159 173 175 263 341 421
Cash & Equivalents
72 29 20 133 165 197
Accounts Receivable
31 47 43 50 63 82
Inventories, net
32 75 84 51 84 111
Prepaid Expenses
23 21 22 24 27 30
Other Current Assets
1.39 1.30 5.14 5.40 2.34 1.43
Plant, Property, & Equipment, net
2.88 2.47 2.08 2.14 2.35 9.30
Total Noncurrent Assets
22 22 21 21 19 30
Goodwill
7.79 7.79 7.79 7.79 7.79 7.79
Noncurrent Deferred & Refundable Income Taxes
0.00 1.27 4.26 6.75 6.10 6.46
Other Noncurrent Operating Assets
4.89 4.76 8.72 6.07 4.85 16
Total Liabilities & Shareholders' Equity
184 197 198 286 362 461
Total Liabilities
82 74 57 83 104 130
Total Current Liabilities
56 74 54 83 103 116
Accounts Payable
16 28 16 22 31 25
Accrued Expenses
34 42 38 60 66 89
Other Current Liabilities
5.36 3.20 0.07 1.21 6.90 1.51
Total Noncurrent Liabilities
26 0.35 2.32 0.66 0.30 13
Other Noncurrent Operating Liabilities
0.48 0.30 2.29 0.65 0.30 13
Commitments & Contingencies
0.00 - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
102 123 141 202 259 332
Total Preferred & Common Equity
102 123 141 202 259 332
Total Common Equity
102 123 141 202 259 332
Common Stock
101 135 146 162 175 186
Retained Earnings
28 47 55 101 157 228
Treasury Stock
-8.93 -59 -59 -60 -72 -83
Accumulated Other Comprehensive Income / (Loss)
-0.95 -0.62 -0.99 -0.65 -0.86 0.49

Quarterly Balance Sheets for Vita Coco

This table presents Vita Coco's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
218 208 245 268 289 323 353 384 421 461 488
Total Current Assets
191 185 224 247 267 301 331 351 387 423 450
Cash & Equivalents
21 29 48 95 123 150 157 154 167 204 202
Accounts Receivable
66 63 90 80 58 79 79 77 103 103 121
Inventories, net
74 64 57 50 57 45 65 88 84 84 86
Prepaid Expenses
22 22 20 18 26 25 28 31 31 29 37
Other Current Assets
7.10 6.67 8.22 4.67 1.77 1.52 2.56 1.58 2.33 2.94 3.59
Plant, Property, & Equipment, net
2.01 2.36 2.22 2.23 2.20 2.23 2.44 2.71 3.46 7.21 9.28
Total Noncurrent Assets
26 20 20 19 18 20 20 30 31 31 29
Goodwill
7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79
Noncurrent Deferred & Refundable Income Taxes
1.09 4.26 4.26 4.25 6.75 6.75 6.76 6.10 6.10 6.10 6.47
Other Noncurrent Operating Assets
9.61 8.18 7.64 6.90 2.99 5.65 5.40 16 17 17 15
Total Liabilities & Shareholders' Equity
218 208 245 268 289 323 353 384 421 461 488
Total Liabilities
77 58 74 76 79 91 101 106 124 138 136
Total Current Liabilities
65 56 71 74 79 91 101 93 110 123 123
Accounts Payable
17 17 19 21 18 21 31 23 26 22 25
Accrued Expenses
46 39 52 51 59 64 65 68 81 100 97
Other Current Liabilities
1.74 0.02 1.09 1.37 1.63 5.97 4.53 3.16 2.80 1.42 0.91
Total Noncurrent Liabilities
12 2.25 2.12 1.84 0.35 0.22 0.32 13 14 14 13
Other Noncurrent Operating Liabilities
2.17 2.22 2.11 1.82 0.34 0.21 0.32 13 14 14 13
Commitments & Contingencies
0.00 - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
142 150 172 193 210 232 252 278 297 324 352
Total Preferred & Common Equity
142 150 172 193 210 232 252 278 297 324 352
Total Common Equity
142 150 172 193 210 232 252 278 297 324 352
Common Stock
144 149 153 159 164 167 170 176 179 183 188
Retained Earnings
58 61 79 94 115 134 153 176 198 222 258
Treasury Stock
-59 -59 -59 -59 -69 -69 -72 -73 -82 -82 -95
Accumulated Other Comprehensive Income / (Loss)
-1.17 -0.82 -0.89 -1.31 -0.66 -0.63 0.16 -0.37 0.83 0.55 0.03

Annual Metrics And Ratios for Vita Coco

This table displays calculated financial ratios and metrics derived from Vita Coco's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 9.40% 22.17% 12.72% 15.39% 4.54% 18.17%
EBITDA Growth
0.00% 219.76% -42.18% -47.47% 309.21% 14.87% 32.92%
EBIT Growth
0.00% 256.49% -44.09% -55.08% 401.18% 15.72% 34.88%
NOPAT Growth
0.00% 217.91% -45.13% -88.58% 1,965.41% 28.29% 8.51%
Net Income Growth
0.00% 246.92% -41.90% -58.86% 496.74% 19.99% 27.47%
EPS Growth
0.00% 250.00% -37.50% -60.00% 464.29% 18.99% 26.60%
Operating Cash Flow Growth
0.00% 53.10% -148.51% 32.36% 1,079.93% -59.97% 9.97%
Free Cash Flow Firm Growth
0.00% 0.00% -0.33% -20.57% 498.23% -64.67% -33.16%
Invested Capital Growth
0.00% 0.00% 71.38% 27.97% -42.21% 34.66% 43.02%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 1.28% 2.95% 4.27% 0.08%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 22.17% 21.76% -9.04% 9.04%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 16.16% 20.07% -9.24% 10.26%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -1.09% 25.28% 1.11% 1.39%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 8.42% 25.87% -5.73% 3.12%
EPS Q/Q Growth
0.00% 0.00% 0.00% 16.67% 23.44% -4.08% 3.48%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -10.61% 39.24% 38.71% -41.34% -18.65%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 40.95% -43.17% -39.75%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -6.88% -28.46% -1.33% 12.20%
Profitability Metrics
- - - - - - -
Gross Margin
32.75% 33.76% 29.81% 24.16% 36.61% 38.52% 36.50%
EBITDA Margin
5.08% 14.84% 7.03% 3.27% 11.61% 12.76% 14.35%
Operating Margin
4.71% 15.08% 6.48% 0.71% 11.44% 14.31% 13.53%
EBIT Margin
4.35% 14.16% 6.48% 2.58% 11.22% 12.42% 14.17%
Profit (Net Income) Margin
3.32% 10.52% 5.00% 1.83% 9.45% 10.84% 11.70%
Tax Burden Percent
82.64% 74.97% 78.39% 72.08% 80.51% 79.04% 76.71%
Interest Burden Percent
92.40% 99.12% 98.52% 98.13% 104.61% 110.48% 107.58%
Effective Tax Rate
17.36% 25.03% 21.61% 27.92% 19.49% 20.96% 23.29%
Return on Invested Capital (ROIC)
0.00% 127.34% 25.74% 2.04% 47.64% 71.12% 55.33%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 137.70% 26.49% -21.01% 46.13% 72.73% 50.90%
Return on Net Nonoperating Assets (RNNOA)
0.00% -63.43% -8.90% 3.87% -20.49% -46.86% -31.17%
Return on Equity (ROE)
0.00% 63.90% 16.85% 5.91% 27.15% 24.26% 24.16%
Cash Return on Invested Capital (CROIC)
0.00% -72.66% -26.86% -22.50% 101.15% 41.58% 19.93%
Operating Return on Assets (OROA)
0.00% 23.92% 12.90% 5.59% 22.91% 19.77% 20.99%
Return on Assets (ROA)
0.00% 17.78% 9.96% 3.95% 19.29% 17.27% 17.32%
Return on Common Equity (ROCE)
0.00% 63.86% 16.84% 5.91% 27.15% 24.26% 24.16%
Return on Equity Simple (ROE_SIMPLE)
0.00% 31.98% 15.42% 5.54% 23.03% 21.62% 0.00%
Net Operating Profit after Tax (NOPAT)
11 35 19 2.20 45 58 63
NOPAT Margin
3.89% 11.31% 5.08% 0.51% 9.21% 11.31% 10.38%
Net Nonoperating Expense Percent (NNEP)
0.00% -10.36% -0.75% 23.05% 1.51% -1.61% 4.43%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.56% 22.46% 22.54% 19.10%
Cost of Revenue to Revenue
67.25% 66.25% 70.19% 75.84% 63.39% 61.48% 63.50%
SG&A Expenses to Revenue
27.79% 23.95% 23.33% 23.45% 25.17% 24.22% 22.97%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
28.04% 18.67% 23.33% 23.45% 25.17% 24.22% 22.97%
Earnings before Interest and Taxes (EBIT)
12 44 25 11 55 64 86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
14 46 27 14 57 66 88
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 1.69 5.03 5.48 7.19 8.09 9.11
Price to Tangible Book Value (P/TBV)
0.00 2.02 5.77 5.80 7.48 8.34 9.32
Price to Revenue (P/Rev)
0.61 0.56 1.63 1.81 2.95 4.06 4.95
Price to Earnings (P/E)
18.32 5.28 32.61 98.91 31.22 37.42 41.54
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.46% 18.93% 3.07% 1.01% 3.20% 2.67% 2.41%
Enterprise Value to Invested Capital (EV/IC)
0.00 2.27 6.26 6.23 18.92 20.49 20.95
Enterprise Value to Revenue (EV/Rev)
0.00 0.40 1.56 1.76 2.68 3.74 4.63
Enterprise Value to EBITDA (EV/EBITDA)
0.00 2.72 22.18 53.78 23.09 29.30 32.25
Enterprise Value to EBIT (EV/EBIT)
0.00 2.85 24.05 68.18 23.90 30.11 32.65
Enterprise Value to NOPAT (EV/NOPAT)
0.00 3.57 30.69 342.10 29.10 33.07 44.57
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 3.76 0.00 0.00 12.35 44.97 59.82
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 13.70 56.56 123.76
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.24 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.24 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -0.46 -0.34 -0.18 -0.44 -0.64 -0.61
Leverage Ratio
0.00 1.80 1.69 1.50 1.41 1.41 1.40
Compound Leverage Factor
0.00 1.78 1.67 1.47 1.47 1.55 1.50
Debt to Total Capital
0.00% 19.67% 0.06% 0.03% 0.01% 0.01% 0.00%
Short-Term Debt to Total Capital
0.00% 0.02% 0.02% 0.02% 0.01% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 19.66% 0.04% 0.02% 0.01% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 80.26% 99.94% 99.97% 99.99% 100.00% 100.00%
Debt to EBITDA
0.00 0.54 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 -1.02 -1.07 -1.40 -2.31 -2.50 -2.25
Long-Term Debt to EBITDA
0.00 0.54 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.71 0.00 0.02 0.00 0.00 0.00
Net Debt to NOPAT
0.00 -1.34 -1.48 -8.89 -2.91 -2.82 -3.11
Long-Term Debt to NOPAT
0.00 0.71 0.00 0.01 0.00 0.00 0.00
Altman Z-Score
0.00 4.64 8.28 11.65 14.11 15.53 17.40
Noncontrolling Interest Sharing Ratio
0.00% 0.08% 0.03% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 2.86 2.34 3.22 3.18 3.31 3.62
Quick Ratio
0.00 1.84 1.03 1.16 2.21 2.21 2.39
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -20 -20 -24 97 34 23
Operating Cash Flow to CapEx
2,157.09% 8,886.13% -2,902.33% -1,113.54% 18,039.56% 4,404.41% 578.89%
Free Cash Flow to Firm to Interest Expense
0.00 -25.34 -40.88 -93.98 3,114.94 0.00 0.00
Operating Cash Flow to Interest Expense
18.71 42.13 -32.86 -42.38 3,456.61 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
17.85 41.65 -33.99 -46.19 3,437.45 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 1.69 1.99 2.16 2.04 1.59 1.48
Accounts Receivable Turnover
0.00 10.18 9.77 9.45 10.57 9.09 8.41
Inventory Turnover
0.00 6.44 4.96 4.07 4.64 4.72 3.97
Fixed Asset Turnover
0.00 107.86 141.79 188.08 234.38 230.00 104.69
Accounts Payable Turnover
0.00 12.99 12.06 14.66 16.58 12.07 13.77
Days Sales Outstanding (DSO)
0.00 35.84 37.36 38.63 34.55 40.15 43.39
Days Inventory Outstanding (DIO)
0.00 56.70 73.54 89.71 78.67 77.29 91.95
Days Payable Outstanding (DPO)
0.00 28.09 30.27 24.89 22.01 30.25 26.50
Cash Conversion Cycle (CCC)
0.00 64.45 80.63 103.45 91.20 87.20 108.83
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 55 95 121 70 94 135
Invested Capital Turnover
0.00 11.26 5.07 3.97 5.17 6.29 5.33
Increase / (Decrease) in Invested Capital
0.00 55 39 26 -51 24 41
Enterprise Value (EV)
0.00 125 591 753 1,323 1,929 2,822
Market Capitalization
173 173 620 773 1,456 2,094 3,019
Book Value per Share
$0.00 $1.75 $2.22 $2.52 $3.57 $4.56 $5.82
Tangible Book Value per Share
$0.00 $1.46 $1.94 $2.38 $3.43 $4.42 $5.69
Total Capital
0.00 127 123 141 202 259 332
Total Debt
0.00 25 0.08 0.05 0.03 0.01 0.00
Total Long-Term Debt
0.00 25 0.05 0.03 0.01 0.00 0.00
Net Debt
0.00 -47 -29 -20 -133 -165 -197
Capital Expenditures (CapEx)
1.01 0.38 0.56 0.98 0.59 0.97 8.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 31 71 101 48 73 108
Debt-free Net Working Capital (DFNWC)
0.00 103 99 121 180 238 305
Net Working Capital (NWC)
0.00 103 99 121 180 238 305
Net Nonoperating Expense (NNE)
1.63 2.44 0.28 -5.61 -1.15 2.40 -8.01
Net Nonoperating Obligations (NNO)
0.00 -47 -29 -20 -133 -165 -197
Total Depreciation and Amortization (D&A)
2.08 2.13 2.07 2.96 1.95 1.77 1.09
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 10.07% 18.61% 23.60% 9.69% 14.22% 17.73%
Debt-free Net Working Capital to Revenue
0.00% 33.31% 26.17% 28.19% 36.54% 46.13% 50.02%
Net Working Capital to Revenue
0.00% 33.30% 26.16% 28.19% 36.54% 46.13% 50.02%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.35 $0.14 $0.83 $0.99 $1.25
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 53.69M 55.73M 56.43M 56.73M 56.91M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.35 $0.14 $0.79 $0.94 $1.19
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 54.19M 56.12M 58.75M 59.29M 59.97M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 55.56M 56.05M 56.93M 56.99M 57.08M
Normalized Net Operating Profit after Tax (NOPAT)
11 23 19 2.20 45 58 63
Normalized NOPAT Margin
3.89% 7.35% 5.08% 0.51% 9.21% 11.31% 10.38%
Pre Tax Income Margin
4.02% 14.04% 6.38% 2.53% 11.73% 13.72% 15.25%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
10.61 55.61 49.99 42.82 1,786.13 0.00 0.00
NOPAT to Interest Expense
9.50 44.41 39.18 8.53 1,467.10 0.00 0.00
EBIT Less CapEx to Interest Expense
9.74 55.14 48.86 39.02 1,766.97 0.00 0.00
NOPAT Less CapEx to Interest Expense
8.63 43.94 38.04 4.73 1,447.94 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.28% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.39% 21.23% 263.57% 0.00% 1.66% 21.50% 15.80%

Quarterly Metrics And Ratios for Vita Coco

This table displays calculated financial ratios and metrics derived from Vita Coco's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 57,082,173.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 57,082,173.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.53
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.30% 15.39% 1.77% 3.20% -3.74% 19.92% 17.21% 17.10% 37.17% 0.39% 37.31%
EBITDA Growth
95.03% 401.43% 88.45% 8.27% 27.85% -93.91% 39.29% 10.79% 21.74% 610.86% 57.77%
EBIT Growth
99.39% 334.19% 93.39% 8.54% 29.34% -100.59% 38.52% 11.68% 21.76% 21,163.16% 57.06%
NOPAT Growth
170.51% 235.70% 184.21% 33.20% -16.78% 89.66% -0.21% -8.96% 41.13% -33.99% 82.79%
Net Income Growth
108.93% 341.03% 112.35% 6.15% 26.95% -50.24% 32.62% 19.98% 24.68% 64.01% 61.39%
EPS Growth
100.00% 300.00% 100.00% 3.23% 23.08% -40.00% 29.17% 18.75% 25.00% 66.67% 61.29%
Operating Cash Flow Growth
189.20% 412.72% -102.83% 61.82% -78.77% -81.37% -3,570.41% -18.98% 318.86% -156.27% 259.18%
Free Cash Flow Firm Growth
278.00% 286.59% 727.60% 115.44% -64.97% -127.81% -150.40% -143.13% -115.49% -124.28% 104.98%
Invested Capital Growth
-24.78% -42.21% -31.54% -33.60% -2.37% 34.66% 50.47% 58.57% 25.78% 43.02% 20.92%
Revenue Q/Q Growth
-1.13% -23.12% 5.23% 29.02% -7.78% -4.22% 2.85% 28.90% 8.03% -29.91% 40.68%
EBITDA Q/Q Growth
-15.76% -63.18% 142.72% 43.83% -0.53% -98.25% 5,454.48% 12.01% 10.45% -71.02% 330.57%
EBIT Q/Q Growth
-16.59% -64.65% 154.23% 44.81% -0.61% -100.16% 60,218.42% 16.75% 8.37% -72.31% 348.29%
NOPAT Q/Q Growth
10.42% -75.21% 224.91% 49.76% -31.02% -43.50% 70.96% 36.62% 6.94% -73.57% 373.37%
Net Income Q/Q Growth
-15.69% -55.34% 110.22% 34.10% 0.83% -82.49% 460.30% 21.32% 4.78% -76.97% 451.37%
EPS Q/Q Growth
-16.13% -61.54% 140.00% 33.33% 0.00% -81.25% 416.67% 22.58% 5.26% -75.00% 400.00%
Operating Cash Flow Q/Q Growth
164.09% -15.43% -100.72% 10,182.02% -65.36% -25.77% -241.58% 322.55% 79.09% -109.97% 500.51%
Free Cash Flow Firm Q/Q Growth
71.33% 9.61% -4.78% 20.47% -72.14% -187.02% -72.57% -3.09% 89.99% -1,159.83% 103.83%
Invested Capital Q/Q Growth
-20.77% -28.46% 18.09% -0.80% 16.49% -1.33% 31.97% 4.54% -7.60% 12.20% 11.58%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.68% 37.50% 42.24% 40.76% 38.80% 32.45% 36.73% 36.30% 37.66% 34.88% 39.95%
EBITDA Margin
13.70% 6.56% 15.14% 16.87% 18.20% 0.33% 17.99% 15.63% 15.98% 6.61% 20.23%
Operating Margin
17.04% 5.11% 16.97% 20.80% 15.50% 3.37% 14.74% 14.89% 15.32% 7.98% 18.68%
EBIT Margin
13.29% 6.11% 14.76% 16.57% 17.86% -0.03% 17.45% 15.80% 15.85% 6.26% 19.96%
Profit (Net Income) Margin
10.98% 6.38% 12.75% 13.25% 14.48% 2.65% 14.42% 13.57% 13.17% 4.33% 16.95%
Tax Burden Percent
79.08% 85.06% 79.03% 74.85% 75.16% 204.12% 77.50% 81.32% 78.24% 56.64% 81.39%
Interest Burden Percent
104.48% 122.75% 109.23% 106.81% 107.90% -4,344.74% 106.64% 105.62% 106.14% 121.91% 104.35%
Effective Tax Rate
20.92% 14.94% 20.97% 25.15% 24.84% -104.12% 22.50% 18.68% 21.76% 43.36% 18.61%
Return on Invested Capital (ROIC)
56.74% 22.46% 65.43% 75.85% 59.67% 43.22% 59.11% 63.99% 67.77% 24.08% 72.96%
ROIC Less NNEP Spread (ROIC-NNEP)
63.19% 19.63% 66.38% 79.22% 56.67% 46.83% 56.31% 62.43% 66.58% 24.22% 71.19%
Return on Net Nonoperating Assets (RNNOA)
-20.14% -8.72% -28.85% -38.95% -32.06% -30.17% -32.42% -37.43% -41.67% -14.83% -40.17%
Return on Equity (ROE)
36.60% 13.74% 36.58% 36.90% 27.62% 13.04% 26.69% 26.56% 26.11% 9.25% 32.79%
Cash Return on Invested Capital (CROIC)
60.17% 101.15% 91.82% 99.73% 62.14% 41.58% 16.02% 7.51% 35.13% 19.93% 36.21%
Operating Return on Assets (OROA)
26.18% 12.48% 29.47% 29.15% 28.44% -0.05% 27.75% 23.78% 23.72% 9.28% 30.14%
Return on Assets (ROA)
21.63% 13.03% 25.44% 23.31% 23.06% 4.22% 22.94% 20.43% 19.70% 6.41% 25.60%
Return on Common Equity (ROCE)
36.60% 13.74% 36.58% 36.90% 27.62% 13.04% 26.69% 26.56% 26.11% 9.25% 32.79%
Return on Equity Simple (ROE_SIMPLE)
19.23% 0.00% 25.83% 23.82% 23.54% 0.00% 21.81% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
19 4.61 15 22 15 8.75 15 20 22 5.77 27
NOPAT Margin
13.47% 4.34% 13.41% 15.57% 11.65% 6.87% 11.42% 12.11% 11.98% 4.52% 15.20%
Net Nonoperating Expense Percent (NNEP)
-6.46% 2.83% -0.96% -3.37% 3.00% -3.62% 2.80% 1.56% 1.20% -0.14% 1.77%
Return On Investment Capital (ROIC_SIMPLE)
- 2.28% - - - 3.38% 5.38% 6.88% 6.75% 1.74% 7.76%
Cost of Revenue to Revenue
59.32% 62.50% 57.76% 59.24% 61.20% 67.55% 63.27% 63.70% 62.34% 65.12% 60.05%
SG&A Expenses to Revenue
23.65% 32.39% 25.26% 19.95% 23.30% 29.08% 21.99% 21.42% 22.35% 26.91% 21.27%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.65% 32.39% 25.26% 19.95% 23.30% 29.08% 21.99% 21.42% 22.35% 26.91% 21.27%
Earnings before Interest and Taxes (EBIT)
18 6.49 16 24 24 -0.04 23 27 29 8.00 36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
19 6.97 17 24 24 0.42 24 26 29 8.45 36
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.63 7.19 6.63 6.80 6.38 8.09 6.29 6.90 7.45 9.11 7.77
Price to Tangible Book Value (P/TBV)
7.95 7.48 6.89 7.04 6.58 8.34 6.47 7.08 7.64 9.32 7.94
Price to Revenue (P/Rev)
3.07 2.95 2.81 3.16 3.25 4.06 3.26 3.66 3.96 4.95 4.15
Price to Earnings (P/E)
39.67 31.22 25.68 28.56 27.08 37.42 28.82 31.80 34.89 41.54 32.83
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.52% 3.20% 3.89% 3.50% 3.69% 2.67% 3.47% 3.14% 2.87% 2.41% 3.05%
Enterprise Value to Invested Capital (EV/IC)
14.06 18.92 15.35 17.44 15.20 20.49 12.82 14.48 18.41 20.95 16.86
Enterprise Value to Revenue (EV/Rev)
2.87 2.68 2.56 2.86 2.93 3.74 2.98 3.36 3.63 4.63 3.85
Enterprise Value to EBITDA (EV/EBITDA)
29.20 23.09 19.43 21.29 20.04 29.30 21.98 25.06 27.53 32.25 25.12
Enterprise Value to EBIT (EV/EBIT)
29.81 23.90 20.02 21.91 20.55 30.11 22.62 25.69 28.19 32.65 25.47
Enterprise Value to NOPAT (EV/NOPAT)
37.87 29.10 22.95 23.45 25.14 33.07 27.35 33.63 35.38 44.57 33.46
Enterprise Value to Operating Cash Flow (EV/OCF)
17.80 12.35 13.01 13.26 19.84 44.97 47.74 66.57 38.10 59.82 34.90
Enterprise Value to Free Cash Flow (EV/FCFF)
20.07 13.70 13.59 13.96 24.17 56.56 96.13 236.63 58.39 123.76 50.97
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.32 -0.44 -0.43 -0.49 -0.57 -0.64 -0.58 -0.60 -0.63 -0.61 -0.56
Leverage Ratio
1.46 1.41 1.38 1.41 1.40 1.41 1.38 1.41 1.41 1.40 1.38
Compound Leverage Factor
1.52 1.73 1.51 1.50 1.51 -61.04 1.47 1.49 1.50 1.70 1.44
Debt to Total Capital
0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.98% 99.99% 99.99% 99.99% 99.99% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-2.02 -2.31 -1.88 -2.24 -2.16 -2.50 -2.12 -2.23 -2.54 -2.25 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
-2.61 -2.91 -2.23 -2.46 -2.72 -2.82 -2.64 -2.99 -3.26 -3.11 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
14.90 13.55 13.76 13.56 12.56 14.95 12.91 12.89 13.51 16.84 15.18
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.34 3.18 3.38 3.31 3.28 3.31 3.76 3.51 3.43 3.62 3.65
Quick Ratio
2.36 2.21 2.29 2.52 2.34 2.21 2.47 2.45 2.49 2.39 2.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
51 56 53 64 18 -15 -27 -28 -2.76 -35 1.33
Operating Cash Flow to CapEx
95,504.35% 56,290.91% -215.32% 9,282.41% 2,143.68% 5,537.60% -1,753.13% 2,298.21% 1,144.42% -120.66% 3,383.95%
Free Cash Flow to Firm to Interest Expense
50,809.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
43,932.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
43,886.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.97 2.04 2.00 1.76 1.59 1.59 1.59 1.50 1.50 1.48 1.51
Accounts Receivable Turnover
6.60 10.57 8.19 5.94 6.26 9.09 7.95 6.17 6.70 8.41 6.67
Inventory Turnover
5.06 4.64 4.98 5.81 5.16 4.72 4.63 5.52 5.22 3.97 4.72
Fixed Asset Turnover
226.21 234.38 217.68 224.53 212.16 230.00 218.24 196.72 126.32 104.69 109.90
Accounts Payable Turnover
16.31 16.58 17.38 15.21 11.30 12.07 16.46 15.39 14.57 13.77 17.38
Days Sales Outstanding (DSO)
55.30 34.55 44.59 61.49 58.33 40.15 45.91 59.14 54.51 43.39 54.75
Days Inventory Outstanding (DIO)
72.08 78.67 73.26 62.82 70.70 77.29 78.92 66.11 69.88 91.95 77.35
Days Payable Outstanding (DPO)
22.38 22.01 21.01 24.00 32.30 30.25 22.17 23.72 25.04 26.50 21.00
Cash Conversion Cycle (CCC)
105.00 91.20 96.84 100.31 96.74 87.20 102.66 101.54 99.35 108.83 111.11
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
98 70 83 82 95 94 124 130 120 135 150
Invested Capital Turnover
4.21 5.17 4.88 4.87 5.12 6.29 5.18 5.29 5.66 5.33 4.80
Increase / (Decrease) in Invested Capital
-32 -51 -38 -41 -2.32 24 42 48 25 41 26
Enterprise Value (EV)
1,375 1,323 1,268 1,429 1,451 1,929 1,593 1,881 2,210 2,822 2,533
Market Capitalization
1,470 1,456 1,391 1,579 1,608 2,094 1,747 2,048 2,413 3,019 2,735
Book Value per Share
$3.41 $3.57 $3.68 $4.09 $4.44 $4.56 $4.88 $5.23 $5.70 $5.82 $6.17
Tangible Book Value per Share
$3.27 $3.43 $3.55 $3.96 $4.30 $4.42 $4.74 $5.10 $5.56 $5.69 $6.03
Total Capital
193 202 210 232 252 259 278 297 324 332 352
Total Debt
0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00
Total Long-Term Debt
0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-95 -133 -123 -150 -157 -165 -154 -167 -204 -197 -202
Capital Expenditures (CapEx)
0.05 0.07 0.12 0.29 0.44 0.13 0.56 0.95 3.41 3.23 0.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
78 48 65 60 73 73 105 110 96 108 125
Debt-free Net Working Capital (DFNWC)
173 180 188 210 230 238 258 277 300 305 326
Net Working Capital (NWC)
173 180 188 210 230 238 258 277 300 305 326
Net Nonoperating Expense (NNE)
3.44 -2.16 0.75 3.35 -3.77 5.38 -3.93 -2.48 -2.16 0.25 -3.14
Net Nonoperating Obligations (NNO)
-95 -133 -127 -150 -157 -165 -154 -167 -204 -197 -202
Total Depreciation and Amortization (D&A)
0.57 0.48 0.42 0.44 0.45 0.46 0.71 -0.29 0.23 0.44 0.48
Debt-free, Cash-free Net Working Capital to Revenue
16.35% 9.69% 13.06% 11.94% 14.82% 14.22% 19.53% 19.59% 15.78% 17.73% 18.92%
Debt-free Net Working Capital to Revenue
36.14% 36.54% 37.88% 41.96% 46.49% 46.13% 48.23% 49.42% 49.22% 50.02% 49.57%
Net Working Capital to Revenue
36.14% 36.54% 37.88% 41.96% 46.49% 46.13% 48.22% 49.42% 49.22% 50.02% 49.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.27 $0.12 $0.25 $0.34 $0.34 $0.06 $0.33 $0.40 $0.42 $0.10 $0.53
Adjusted Weighted Average Basic Shares Outstanding
56.49M 56.43M 56.59M 56.71M 56.77M 56.73M 56.99M 56.80M 56.85M 56.91M 57.11M
Adjusted Diluted Earnings per Share
$0.26 $0.10 $0.24 $0.32 $0.32 $0.06 $0.31 $0.38 $0.40 $0.10 $0.50
Adjusted Weighted Average Diluted Shares Outstanding
59.27M 58.75M 58.75M 59.24M 59.31M 59.29M 59.98M 59.64M 59.88M 59.97M 60.47M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
56.76M 56.93M 56.68M 56.78M 56.73M 56.99M 56.73M 56.82M 56.95M 57.08M 57.11M
Normalized Net Operating Profit after Tax (NOPAT)
19 4.61 15 22 15 3.00 15 20 22 5.77 27
Normalized NOPAT Margin
13.47% 4.34% 13.41% 15.57% 11.65% 2.36% 11.42% 12.11% 11.98% 4.52% 15.20%
Pre Tax Income Margin
13.89% 7.50% 16.13% 17.70% 19.27% 1.30% 18.61% 16.69% 16.83% 7.64% 20.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
18,352.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
18,601.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
18,306.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
18,555.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 1.66% 18.48% 18.11% 21.57% 21.50% 7.09% 19.95% 14.75% 15.80% 25.66%

Financials Breakdown Chart

Key Financial Trends

Here are key trends from Vita Coco's quarterly statements (COCO) across the last four years, focusing on revenue, profitability, liquidity, and balance-sheet strength.

  • Strong cash balance and liquidity: Cash and equivalents rose to a robust level through 2024–2025, with roughly $203M by 2025 Q3 and continued liquidity support, improving financial flexibility.
  • Stable gross margins: Gross margins have generally sat in the mid-30s percentage range across 2023–2025 (roughly 35%), signaling consistent profitability on product mix.
  • Solid year-over-year net income growth in 2024–2025: Net income improved in 2024 versus 2023, with quarterly strength continuing into 2025 (e.g., 24.0M in 2025 Q3 and 22.9M in 2025 Q2).
  • Revenue volatility by quarter: Revenue fluctuates quarter-to-quarter (roughly $110M–$180M range in 2025), with a notable mid-year peak in 2025 Q3, which can complicate near-term forecasting.
  • Balance-sheet growth supported by equity, modest debt: Total assets and equity trended higher into 2025 (assets around $461M in 2025 Q3; equity around $323M), while long-term debt remains minimal or zero, indicating a conservative capital structure.
  • Capex and investing activity modest: Cash used for investing is small and relatively steady (low single-digit millions per quarter), contributing to negative investing cash flow but reflecting controlled capital expenditure.
  • Negative cash flow from operations in some quarters: Notably, 2025 Q4 and 2025 Q1 show negative net cash from continuing operating activities (about -$3.9M and -$9.8M respectively), signaling cash-generation variability in the short term.
  • Cash burn and net change in cash in certain periods: 2025 Q4 shows a negative net change in cash of about -$6.83M despite positive net income, suggesting working-capital or financing effects impacting cash.
  • Financing activities include stock repurchases: Cash outflows for share repurchases occurred in several quarters, which reduces cash and may weigh on liquidity if earnings falter.
  • EPS volatility across quarters: EPS swings from roughly $0.10 in 2025 Q4 to $0.42 in 2025 Q3 (and around $0.33–$0.40 in other quarters), reflecting quarterly earnings volatility relative to fluctuating share counts.
05/06/26 06:56 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Vita Coco's Financials

When does Vita Coco's fiscal year end?

According to the most recent income statement we have on file, Vita Coco's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Vita Coco's net income changed over the last 6 years?

Vita Coco's net income appears to be on an upward trend, with a most recent value of $71.32 million in 2025, rising from $9.42 million in 2019. The previous period was $55.95 million in 2024. See Vita Coco's forecast for analyst expectations on what’s next for the company.

What is Vita Coco's operating income?
Vita Coco's total operating income in 2025 was $82.53 million, based on the following breakdown:
  • Total Gross Profit: $222.60 million
  • Total Operating Expenses: $140.06 million
How has Vita Coco's revenue changed over the last 6 years?

Over the last 6 years, Vita Coco's total revenue changed from $283.95 million in 2019 to $609.78 million in 2025, a change of 114.7%.

How much debt does Vita Coco have?

Vita Coco's total liabilities were at $129.62 million at the end of 2025, a 25.2% increase from 2024, and a 58.9% increase since 2020.

How much cash does Vita Coco have?

In the past 5 years, Vita Coco's cash and equivalents has ranged from $19.63 million in 2022 to $196.87 million in 2025, and is currently $196.87 million as of their latest financial filing in 2025.

How has Vita Coco's book value per share changed over the last 6 years?

Over the last 6 years, Vita Coco's book value per share changed from 0.00 in 2019 to 5.82 in 2025, a change of 582.2%.



Financial statements for NASDAQ:COCO last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners